Non-Invasive Prenatal Testing Market - Forecast (2021 - 2026)
Non-Invasive Prenatal Testing Market size is estimated to reach $9.8 billion by 2026, growing at a CAGR of 13.1% during the forecast period 2021-2026. Prenatal testing is a procedure of determining the risk of whether the fetus of the mother will be born with any genetic abnormalities. This method also analyzes fragments of Deoxyribonucleic acid (DNA) that are circulating in pregnant blood. This non-invasive prenatal testing has grown out of a desire to avoid direct contact with the fetus. The rise in the adoption of cell-free DNA screening for predicting the risk of genetic conditions, growing adoption of ultrasound detection methods in hospitals, increase in the risk of chromosomal abnormalities with rising maternal age, and growing demand for chorionic villus sampling and amniocentesis in diagnostic laboratories are the factors that are set to drive the growth of the Non-Invasive Prenatal Testing Market for the period 2021-2026. Report Coverage The report: “Non-Invasive Prenatal Te...